Related Experiment Video

Updated: Jun 11, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease

Hanna Shevalye1, Yury Maksimchyk, Pierre Watcho

  • 1Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, LA, USA.

Biochimica Et Biophysica Acta
|July 13, 2010
PubMed

Insights

Poly(ADP-ribose)polymerase-1 (PARP-1) deficiency alleviates diabetic kidney disease. PARP-1 gene knockout reduced albuminuria and kidney hypertrophy in diabetic mice.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Genetics

Background:

  • Diabetic nephropathy is a major complication of diabetes.
  • Poly(ADP-ribose)polymerase (PARP) inhibitors show potential in preventing diabetic nephropathy.
  • The specific role of PARP-1 in diabetic kidney disease pathogenesis remains unclear.

Purpose of the Study:

  • To investigate the role of PARP-1 in the development of diabetic kidney disease.
  • To evaluate the therapeutic potential of targeting PARP-1 in diabetic nephropathy.

Main Methods:

  • Utilized PARP-1-deficient (PARP-1-/-) and wild-type (WT) mice.
  • Induced diabetes using streptozotocin in both groups.
  • Assessed kidney function and histology after 12 weeks of diabetes.

Main Results:

  • PARP-1 deficiency significantly reduced albuminuria and prevented kidney hypertrophy in diabetic mice.
  • Histological analysis revealed decreased mesangial expansion and collagen deposition in PARP-1-/- mice.
  • While trends suggested reduced podocyte loss and specific molecular markers, statistical significance was not achieved for these parameters.

Conclusions:

  • PARP-1 gene deficiency alleviates key features of diabetic kidney disease.
  • Targeting PARP-1 may offer a therapeutic strategy for diabetic nephropathy, although it does not completely prevent the condition.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.